- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
KRT8 antibody is useful for studying KRT8, also known as Cytokeratin 8 (CK8) or Keratin 8, a type II intermediate filament protein that serves as a major structural component of simple epithelial cells. KRT8 forms obligate heteropolymers with Cytokeratin 18 to create intermediate filament networks that maintain cellular architecture, provide mechanical stability, and protect epithelial cells from physiologic stress. As one of the most broadly expressed epithelial cytokeratins, KRT8 is widely used as a marker of epithelial differentiation and cellular lineage.
Cytokeratin 8 is expressed throughout numerous simple epithelial tissues, including the gastrointestinal tract, respiratory epithelium, liver, pancreas, kidney, mammary gland, and other glandular organs. In addition to its structural role, KRT8 participates in cellular processes involving apoptosis, signal transduction, migration, proliferation, and stress-response pathways. Interactions between KRT8 and intracellular signaling proteins demonstrate that intermediate filaments contribute to cellular regulation as well as cytoskeletal organization.
KRT8 is among the most extensively studied epithelial markers in both biomedical research and diagnostic pathology. Because Cytokeratin 8 expression is retained in many epithelial-derived malignancies, antibodies against KRT8 are frequently used to identify carcinomas and distinguish epithelial tumors from neoplasms of mesenchymal, hematopoietic, or neural origin. Evaluation of KRT8 expression can provide valuable information regarding epithelial lineage, tissue origin, differentiation status, and tumor-associated phenotypes.
Altered expression, localization, or organization of Cytokeratin 8 has been associated with epithelial injury, inflammation, fibrosis, and cancer progression. Changes in KRT8 expression patterns are frequently observed during malignant transformation and may correlate with alterations in epithelial differentiation, invasive potential, and cellular adaptation to environmental stress. Consequently, KRT8 remains an important biomarker in studies investigating epithelial biology, tumor development, and disease-associated cytoskeletal remodeling.
Because of its widespread expression throughout epithelial tissues, KRT8 is commonly incorporated into multi-marker antibody panels used for tissue classification, tumor characterization, and studies of epithelial differentiation. Cytokeratin 8 is often evaluated alongside Cytokeratin 18, Cytokeratin 19, Cytokeratin 7, EpCAM, and other epithelial markers to assess lineage relationships and phenotypic changes associated with development, disease progression, and cellular transformation.
This KRT8 antibody is recombinantly produced by expression in CHO cells.
KRT8 antibodies are commonly utilized in immunohistochemistry, western blotting, immunofluorescence, flow cytometry, and related protein detection applications. These reagents support investigations of epithelial cell biology, intermediate filament organization, carcinoma pathology, tissue differentiation, and cellular stress responses. KRT8 antibody tools help researchers characterize epithelial populations, evaluate tumor-associated expression patterns, and investigate the biologic functions of this important cytoskeletal protein.
Researchers seeking protein microarray validated detection of Keratin 8 for epithelial differentiation, cytoskeletal biology, and cancer research applications may also be interested in our Cytokeratin 8 Antibody page.
Optimal dilution of the KRT8 antibody should be determined by the researcher.
Recombinant full-length human KRT8 protein was used as the immunogen for the recombinant KRT8 antibody.
Aliquot the KRT8 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Cytokeratin 8 Antibody, CK8 Antibody, Keratin 8 Antibody, Keratin Type II Cytoskeletal 8 Antibody, Intermediate Filament Protein 8 Antibody, Simple Epithelial Keratin Antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.